Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1 1
    France Germany Hungary Italy The Netherlands Poland +3
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Belgium Spain
  • Study on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy

    Not recruiting

    2 1 1
    Investigated drugs:
    France Spain
  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Bulgaria France Germany Italy Poland +1
  • Study to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    France Greece Romania Spain
  • Study of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Spain
  • Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Denmark France Germany Greece Hungary +4
  • Study on Vudalimab or Pembrolizumab with Chemotherapy for Advanced Non-small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Greece The Netherlands Poland Portugal Romania +1
  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Austria Belgium France Germany Greece Hungary +6